The stock of 908 Devices Inc (MASS) closed the recent trading session at $15.54, losing 1.96% from the previous trading session. During the last check, the stock of MASS followed a bullish pattern in the after-hours, gaining 6.82% to $16.6. The company released the fiscal performance for Q4 and FY2021. Also, MASS filed form 8-K with the SEC on 7 March 2022.
908 Devices Inc participates in the advancement of estimation gadgets for synthetic and biochemical analysis. MASS spec gadgets provide solutions to resolve issues in life sciences research, bioprocessing, modern biotechnology, crime scene investigation, and adjoining markets. Currently, MASS has a market capitalization of $433.57 million with 27.90 million shares pending. 908 devices have their headquarter in Boston, Massachusetts, United States of America (USA).
MASS Financials
On 7 March 2022, MASS released the fiscal performance for Q4 and FY2021, which ended on 31 December 2021. The main points of the fiscal performance are
- The company reported total sales to be $15.5 million in Q4 of FY2021 versus $5.91 million in Q4 of FY2020. This marks an expansion of 163%. Also, the total sales in FY2021 grew by 66% to $41.1 million compared to $24.7 million in FY2020.
- The profit increased by 254.1% to $9.1 million in Q4 of FY2021 against $2.5 million in Q4 of FY2020. Further, the profit in FY2021 surged by 55% to $23.2 million from $14.9 million in FY2020.
- MASS had a total loss of $3.4 million in Q4 of FY2021 against $10.2 million in the same year-ago period. The total loss was reduced by 66.6%. Moreover, the total loss in FY2021 grew by 72.9% to $22.1 million versus $12.8 million in FY2020.
- Further, the loss of $0.12 and $0.79 per stock in Q4 and FY2021, respectively.
The CEO of MASS, Kevin J. Knopp, commented that 2021 was a critical year for them. He further added that the firm showed operational greatness during the first year as a public organization. Moreover, Mr. Knopp concluded that they are well situated to serve the need for analytics.
